Global Cord Blood Corporation (CO) Tops Q2 EPS by 3c

Global Cord Blood Corporation (NYSE: CO) reported Q2 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $39.36 million.

For earnings history and earnings-related data on Global Cord Blood Corporation (CO) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• SPS Commerce (SPSC) Tops Q1 EPS by 12c
• AptarGroup (ATR) Tops Q1 EPS by 11c